AI Article Synopsis
Article Abstract
Positron emission tomography (PET) is now regularly used in the diagnosis and staging of cancer. These uses and its ability to monitor treatment response would be aided by the development of imaging agents that can be used to measure tissue and tumor proliferation. We have developed and tested [F-18]FLT (3'-deoxy-3'-fluorothymidine); it is resistant to degradation, is retained in proliferating tissues by the action of thymidine kinase 1 (TK), and produces high-contrast images of normal marrow and tumors in canine and human subjects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/3337 | DOI Listing |
Publication Analysis
Top Keywords
positron emission
8
emission tomography
8
imaging proliferation
4
proliferation vivo
4
vivo [f-18]flt
4
[f-18]flt positron
4
tomography positron
4
tomography pet
4
pet regularly
4
regularly diagnosis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!